LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 27.49 | 27.76 | 7 | 1723 | 0.0041 | -0.2065 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 27.49 | 27.76 | 753 | 1723 | 0.4370 | 0.7405 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 29.19 | 27.76 | 3 | 1863 | 0.0016 | -0.3069 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 29.19 | 27.76 | 516 | 1863 | 0.2770 | 0.6186 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 29.19 | 27.76 | 1 | 1863 | 0.0005 | -0.4217 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 29.19 | 27.76 | 706 | 1863 | 0.3789 | 0.7045 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 30.90 | 27.76 | 3 | 2032 | 0.0015 | -0.3018 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 30.90 | 27.76 | 474 | 2032 | 0.2332 | 0.5811 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 30.90 | 27.76 | 1 | 2032 | 0.0005 | -0.4153 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 30.90 | 27.76 | 624 | 2032 | 0.3070 | 0.6529 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 32.60 | 27.76 | 1 | 2235 | 0.0004 | -0.4084 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 32.60 | 27.76 | 411 | 2235 | 0.1838 | 0.5306 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 32.60 | 27.76 | 1 | 2235 | 0.0004 | -0.4084 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 32.60 | 27.76 | 492 | 2235 | 0.2201 | 0.5747 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 34.30 | 27.76 | 1 | 2449 | 0.0004 | -0.4020 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 34.30 | 27.76 | 397 | 2449 | 0.1621 | 0.5092 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 34.30 | 27.76 | 1 | 2449 | 0.0004 | -0.4020 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 34.30 | 27.76 | 489 | 2449 | 0.1996 | 0.5587 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 36.01 | 27.76 | 1 | 2662 | 0.0004 | -0.3964 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 36.01 | 27.76 | 553 | 2662 | 0.2077 | 0.5753 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 36.01 | 27.76 | 1 | 2662 | 0.0004 | -0.3964 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 36.01 | 27.76 | 429 | 2662 | 0.1611 | 0.5157 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 37.71 | 27.76 | 3 | 2877 | 0.0010 | -0.2827 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 37.71 | 27.76 | 592 | 2877 | 0.2057 | 0.5793 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 37.71 | 27.76 | 1 | 2877 | 0.0003 | -0.3913 | MN20160318_Q01 | L09 |